Data Standards for Tobacco Research and Scientific Review Phase 2
🏛 Food and Drug Administration (HHS-FDA)
✓ Free, no account · Source: Grants.gov · Last verified Jul 15, 2026
Can you apply?
This grant is for research institutions, academic centers, and organizations developing data standards that support tobacco research and scientific review processes. The FDA funds Phase 2 projects that build on initial Phase 1 groundwork to establish, validate, and disseminate standardized data collection, management, and reporting methodologies for tobacco product research and regulatory science. Applicants must demonstrate capacity to conduct collaborative research with FDA components and other stakeholders, and projects should advance the agency's tobacco regulatory mission under the Family Smoking Prevention and Tobacco Control Act. Geographic scope is nationwide, and activities include developing technical standards, creating implementation guidance, testing data standards in real-world research settings, and producing documentation and training materials.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- May 4, 2023 Applications open
- Dec 1, 2023 Application deadline
- May 1, 2024 Project start
Program description
To support high-quality tobacco research, streamline scientific review, and evaluation, and ultimately, improve public health outcomes related to tobacco use, the Center for Tobacco Products (CTP) at the Food and Drug Administration (FDA) is welcoming applications for data standards and terminologies development projects. The primary objective is to support open, consensus-based, data standards for use in studies of tobacco products. Secondary objective is to promote and educate federal regulators, tobacco industry, and global organizations on the use of standardized data to facilitate data sharing, integration, and analysis. Projects may focus on solutions to data standards and terminologies development and implementation challenges and/or on specific concepts, domains, or areas where standardization is needed.
Who can apply
Eligible applicants
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (Application for Federal Assistance)
- Project narrative/technical approach
- Budget and budget justification
- Organizational capacity and qualifications
- Letters of support from FDA and key research partners
- Data management and quality assurance plan
- Timeline and milestones for Phase 2 activities
- Evidence of Phase 1 accomplishments (if applicable)
- Curriculum vitae of key personnel
Program contact
- 👤 Rene A Vasquez Grants Management Specialist
- 📧 rene.vasquez@fda.hhs.gov
- 📞 301-796-3546
Funding track record
Recent awards under CFDA 93.103 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$121,795,918
-
$76,105,626
-
$50,217,964
-
$47,940,304
-
$36,000,000
-
$35,573,997
-
$35,391,995
-
$30,732,300
-
$23,332,999
-
$21,347,288
Top States by Funding
- AZ 3 awards $131.4M
- MD 7 awards $108.7M
- CA 9 awards $106.5M
- VA 5 awards $96.6M
- PA 10 awards $77.4M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.103). How funding has trended year over year.
| 2016 | $170,482,435 | |
| 2017 est. | $208,900,832 | |
| 2018 | $173,077,408 | |
| 2019 | $198,507,896 | |
| 2020 | $212,448,590 | |
| 2021 | $218,918,739 | |
| 2022 est. | $255,910,458 | |
| 2023 est. | $246,894,600 |
FAQ
Who is eligible to apply for this grant?
Research institutions, universities, public health organizations, nonprofit research centers, and other entities with demonstrated expertise in tobacco research and data management can apply. Applicants should have experience in Phase 1 work or related standards development.
What types of activities does this grant support?
Phase 2 activities typically include refining data standards, validating standards across multiple research sites, developing implementation protocols, creating user guidance, training researchers, and producing technical documentation.
Is there a funding cap or typical award range?
Award amounts vary; consult the specific funding announcement for current award ranges and any restrictions on budget size.
What makes an application competitive?
Competitive applications clearly show how Phase 2 work builds on earlier Phase 1 accomplishments, demonstrate strong stakeholder partnerships (including FDA engagement), provide realistic timelines, and address gaps in tobacco research standardization.
What is the deadline, and how often does this grant open?
The specific deadline is not listed in the basic grant facts. Check Grants.gov or the FDA's official announcements for current application deadlines and future funding cycles.
💡 Tips for applicants
- Build on Phase 1 work: Clearly document what was accomplished in Phase 1 and explain how Phase 2 activities directly advance that foundation.
- Engage stakeholders early: Include letters of support from FDA contacts, research partners, and organizations that will use the data standards.
- Show implementation pathways: Describe how researchers and tobacco product manufacturers will actually adopt and benefit from the standards you develop.
- Plan for sustainability: Address how the standards will be maintained, updated, and disseminated beyond the grant period.
- Address technical rigor: Include detailed methods for validating standards across diverse research settings and demonstrating their effectiveness.
⚠️ Common mistakes
Applications often fail because they do not clearly articulate how Phase 2 work advances Phase 1 deliverables or they lack meaningful FDA partnership and engagement. Weak applications also underestimate the complexity of achieving buy-in across diverse research institutions and failing to provide concrete implementation plans for how the standards will be adopted in practice.
Similar grants
- CLOSED High-Priority Research in Tobacco Regulatory Science (Clinical Trial Optional) — National Institutes of Health
- OPEN Tobacco Centers of Regulatory Science (TCORS) (Clinical Trial Optional) — National Institutes of Health
- CLOSED Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional) — National Institutes of Health
- CLOSED Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN RFA-TP-18-000 — Centers for Disease Control and Prevention - ERA